REGENXBIO Inc. (RGNX)
NASDAQ: RGNX · Real-Time Price · USD
9.49
+0.30 (3.26%)
At close: Apr 17, 2026, 4:00 PM EDT
9.53
+0.04 (0.42%)
After-hours: Apr 17, 2026, 7:57 PM EDT
REGENXBIO Stock Forecast
Stock Price Forecast
The 8 analysts that cover REGENXBIO stock have a consensus rating of "Strong Buy" and an average price target of $28.75, which forecasts a 202.95% increase in the stock price over the next year. The lowest target is $12 and the highest is $50.
Price Target: $28.75 (+202.95%)
Analyst Consensus: Strong Buy
* Price targets were last updated on Mar 9, 2026.
Analyst Ratings
The average analyst rating for REGENXBIO stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 3 | 3 | 3 | 3 | 3 |
| Buy | 3 | 4 | 4 | 4 | 4 | 4 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 8 | 8 | 8 | 8 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $32 → $30 | Strong Buy | Maintains | $32 → $30 | +216.12% | Mar 9, 2026 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $18 → $17 | Buy | Maintains | $18 → $17 | +79.14% | Mar 6, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $34 → $32 | Strong Buy | Maintains | $34 → $32 | +237.20% | Feb 10, 2026 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $14 → $12 | Hold | Maintains | $14 → $12 | +26.45% | Feb 10, 2026 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $25 → $18 | Buy | Maintains | $25 → $18 | +89.67% | Feb 10, 2026 |
Financial Forecast
Revenue This Year
257.72M
from 170.44M
Increased by 51.21%
Revenue Next Year
306.90M
from 257.72M
Increased by 19.08%
EPS This Year
-2.52
from -3.76
EPS Next Year
-2.87
from -2.52
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 408.5M | 563.3M | |||
| Avg | 257.7M | 306.9M | |||
| Low | 132.3M | 155.8M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 139.6% | 118.6% | |||
| Avg | 51.2% | 19.1% | |||
| Low | -22.4% | -39.6% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 1.69 | 0.64 | |||
| Avg | -2.52 | -2.87 | |||
| Low | -4.77 | -6.21 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.